S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Gilles Guillon · Study
Home
/
Author
Gilles Guillon
7 works
· latest 2014
· 3 institutions
cluster: provisional
Follow
Claim this profile
h-index
7
i10
7
Citations
1,543
Works here
7
86
99
02
08
12
14
Most cited in this library
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
2012 · 421 citations
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆
2008 · 294 citations
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.
1986 · 276 citations
Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist
2002 · 211 citations
An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism
2014 · 194 citations
Works
7 shown
An Early Postnatal Oxytocin Treatment Prevents Social and Learning Deficits in Adult Mice Deficient for Magel2, a Gene Involved in Prader-Willi Syndrome and Autism
Biological Psychiatry
·
2014
·
11 authors
194
citations
Oxytocin and Vasopressin Agonists and Antagonists as Research Tools and Potential Therapeutics
Journal of Neuroendocrinology
·
2012
·
9 authors
·
review
·
Open access
421
citations
Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents☆
Progress in brain research
·
2008
·
5 authors
·
chapter
294
citations
[1-Deamino-4-Cyclohexylalanine] Arginine Vasopressin: A Potent and Specific Agonist for Vasopressin V1b Receptors
Endocrinology
·
2002
·
9 authors
76
citations
Characterization of (2 S,4 R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1 H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a Selective and Orally Active Vasopressin V1b Receptor Antagonist
Journal of Pharmacology and Experimental Therapeutics
·
2002
·
15 authors
·
Open access
211
citations
Molecular pharmacology of AVP and OT receptors and therapeutic potential
Drug News & Perspectives
·
1999
·
9 authors
71
citations
Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis.
Molecular Pharmacology
·
1986
·
8 authors
276
citations